Category: Drug safety alert
-
Safety alert: Recall of Lamotrigine Tablets
Taro Pharmaceuticals U.S.A., Inc is voluntarily recalling one lot of Lamotrigine 100 mg Tablets, Lot # 331771 (expiration date June 2021) in 100 count bottles, NDC 51672-4131-1 to the consumer level. This single lot of Lamotrigine 100 mg Tablets Lot #331771 (expiration date June 2021) was found to have been cross-contaminated with a small amount…
-
Recall of heartburn medication Nizatidine
Mylan N.V. announced a recall of three lots of Nizatidine, which is used to treat duodenal ulcers and acid reflux. Trace amounts of NDMN-(N- nitrosodimethylamine) found in the drug, which was manufactured by Solara Active Pharma Sciences Limited. Nizatidine is indicated for the short-term treatment (up to 8 weeks) of active duodenal ulcers and active…
-
Safety alert: Ondansetron – Should Not Be Used During The First Trimester Of Pregnancy To Treat Nausea And Vomiting
Ondansetron is a medication used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, or surgery. It is also useful in gastroenteritis. Ondansetron has also been prescribed during pregnancy to reduce symptoms of nausea and vomiting in pregnancy (NVP). NVP is also referred to as “morning sickness”. Ondansetron is commonly sold under the…
-
Safety Alert: Serious immune system reaction with seizure and mental health medicine Lamotrigine
Lamotrigine is an anti-convulsant medication to treat seizures in epileptic patients. It is also used to control extreme mood swings in bipolar disorder – a medical condition that results in unusual shifts of mood, energy levels and the ability to carry out day-to-day tasks. Lamotrigine works by restoring a balance of certain natural substances in…
-
Recall alert – Mavidon skin preparation products
Mavidon is recalling all lots of Lemon Prep, Pedia Prep, Wave Prep, Cardio Prep Single use cups, Collodions, Collodion Remover, Medical Adhesive Remover, Acetone and all products manufactured by Mavidon immediately due to contamination with multi-drug-resistant Burkholderia cepacia, a bacteria that may cause serious infection. The company has received one report of an adverse event…
-
SAFETY ALERT – Drug labelling error – Mirtazapine Tablets (Aurobindo Pharma – USA)
Aurobindo Pharma, is voluntarily recalling lot number 03119002A3 of Mirtazapine Tablets. The product is being recalled due to a label error on declared strength; bottles labeled as Mirtazapine 7.5 mg may contain 15 mg tablets. Mirtazapine tablets are indicated for the treatment of major depressive disorder. Taking a higher dose than expected, may increase risk…
-
GILENYA (fingolimod) – Safety update
GILENYA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults and children 10 years of age and older. This is the only FDA approved treatment for people with relapsing multiple sclerosis as young as 10. The most…
-
Paracetamol: Dangerous When Not Used Correctly
Paracetamol, also known as acetaminophen and APAP, is a medication used to treat pain and fever. It is typically used for mild to moderate pain relief. It is often sold in combination with other medications, such as in many cold medications. Paracetamol is an effective, simple analgesic that is well tolerated by adults and children…
-
Montelukast: Risk Of Neuropsychiatric Reactions
Montelukast is the leukotriene receptor antagonist. It works by blocking the action of leukotriene D4 in the lungs resulting in decreased inflammation and relaxation of smooth muscle. It is used for a number of conditions including asthma, exercise induced bronchospasm, allergic rhinitis, and urticaria. It is mainly used as a complementary therapy in adults in…